HMN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction PVLA Q1 2026 Earnings EPS Misses Estimates Amid Continued RD Investment HCAT Q1 2026 Earnings EPS Surpasses Estimates on Improved Operations Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress BFAM Q1 2026 Earnings EPS Beat Sends Stock Modestly Higher Revenue Details Unclear Ituran ITRN Q4 2025 Earnings EPS Slightly Beats Estimates Amid Positive Stock Movement